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Background: Data on cancers is a challenge in most developing countries. Population-based cancer registries are
also not common in developing countries despite the usefulness of such registries in informing cancer prevention
and control programmes. The availability of population-based data on cancers in Africa varies across different
countries. In Ghana, data and research on cancer have focussed on specific cancers and have been hospital-based
with no reference population. The Kumasi Cancer Registry was established as the first population-based cancer
registry in Ghana in 2012 to provide information on cancer cases seen in the city of Kumasi.
Methods: This paper reviews data from the Kumasi Cancer Registry for the year 2012. The reference geographic
area for the registry is the city of Kumasi as designated by the 2010 Ghana Population and Housing Census. Data
was from all clinical departments of the Komfo Anokye Teaching Hospital, Pathology Laboratory Results, Death
Certificates and the Kumasi South Regional Hospital. Data was abstracted and entered into Canreg 5 database.
Analysis was conducted using Canreg 5, Microsoft Excel and Epi Info Version 7.1.2.0.
Results: The majority of cancers were recorded among females accounting for 69.6% of all cases. The mean age at
diagnosis for all cases was 51.6 years. Among males, the mean age at diagnosis was 48.4 compared with 53.0 years
for females. The commonest cancers among males were cancers of the Liver (21.1%), Prostate (13.2%), Lung (5.3%)
and Stomach (5.3%). Among females, the commonest cancers were cancers of the Breast (33.9%), Cervix (29.4%),
Ovary (11.3%) and Endometrium (4.5%). Histology of the primary tumour was the basis of diagnosis in 74% of cases
with clinical and other investigations accounting for 17% and 9% respectively. The estimated cancer incidence Age
Adjusted Standardised Rate for males was 10.9/100,000 and 22.4/100, 000 for females.
Conclusion: This first attempt at population-based cancer registration in Ghana indicates that such registries are
feasible in resource limited settings as ours. Strengthening Public Health Surveillance and establishing more
Population-based Cancer Registries will help improve data quality and national efforts at cancer prevention and
control in Ghana.Background
Quality data on cancer in developing countries especially
sub-Saharan Africa is a challenge for most countries [1].
Cancer registries, which are health units concerned with
collecting systematically data on cancers, are useful
sources of evidence on cancers. These centres when well
established can provide high quality data on cancers as* Correspondence: dlaryea@kathhsp.org
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unless otherwise stated.has been advocated for [2] and are useful in planning
cancer prevention and control activities [1]. Population-
based cancer registries (PBCR) are forms of cancer regis-
tries which provide information on cancers in a defined
population. PBCRs are useful in estimating the incidence
of cancer in specified populations. PBCRs are however
not common in Africa and is highlighted by the poor
representation of Africa in the global cancer estimates
published by the World Health Organisation [3]. There
are a handful of PBCRs in Africa with the African Cancer
Registry Network (AFCRN) currently championing the
cause for the establishment of more PBCRs in AfricaLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Laryea et al. BMC Cancer 2014, 14:362 Page 2 of 8
http://www.biomedcentral.com/1471-2407/14/362[4]. Some nationally-based PBCRs exist in countries
like The Gambia [5], city-based ones as the Ibadan and
Abuja registries in Nigeria [6] or regional ones as the
Eldoret Registry in Kenya [7].
Geographical location [8] or occupational settings [9]
have been identified as risk factors for cancer in Ghana.
Although smoking is not a significant public health issue
in Ghana [10-12] unacceptably high levels of second
hand smoking have been found in some places [9]. The
recently passed Public Health Act outlaws smoking in
public places and is seen as useful in reducing not only
the incidence of second-hand smoking but smoking
prevalence overall [13]. Human Herpes Virus 8 (HHV 8)
associated with Kaposi Sarcoma has also been found to
be highly prevalent in Ghana [14] as has Human Papil-
loma Virus (HPV) infections [15]. Despite the lack of
population-based data on cancer in Ghana, there is some
evidence of the public health importance of cancer in
Ghana [16,17]. The need to develop a comprehensive
programme on non-communicable disease control in-
cluding cancers in Ghana has been highlighted [18,19].
Currently some activities with implications for cancer
control and prevention are ongoing in Ghana. Hepatitis B
vaccination is an integral part of Ghana’s immunisation
programme and may contribute to reducing the incidence
of hepatitis B and possibly, liver cancer. Screening for spe-
cific cancers such as cervical cancer, although available,
has been found to be low [18] while some attempts have
also been made to introduce other methods of screening
for some cancers hitherto not available in Ghana [20].
The burden of cancer in Ghana has not been static. Sev-
eral studies on cancers in Ghana have focussed largely on
cancers of specific sites [21-23] including the stages of
presentation and have mainly been institutionally-based
with no reference population [16,17,24,25]. There is the
need for more comprehensive studies focussing on po-
pulations [26] in order to provide accurate information
on cancers for action [2,27]. Some attempts have been
made at collecting population-based cancer data in Ghana
[28]. Cancer registration particularly population-based
ones remain rare in Ghana. The Kumasi Cancer Registry
was established in 2012 with the objective of providing
population-based data on cancers in Kumasi. We set out
to describe cancer cases seen in Kumasi and to estimate
incidence using data from the Kumasi Cancer Registry
in 2012.
Methods
This paper reviews data from the Kumasi Cancer Registry
(KsCR) for 2012. The KsCR is a member of the AFCRN
and started as a hospital-based cancer registry (HBCR) in
2004. It was converted to a PBCR in 2012 with the initial
aim of providing data on cancers in the population of
Kumasi and subsequently, the Ashanti Region of Ghana.The reference geographic area for the registry is the city of
Kumasi as designated by the 2010 Ghana Population and
Housing Census.
We reviewed data collected from all clinical depart-
ments and the Pathology Department of the Komfo
Anokye Teaching Hospital (KATH), Private Laboratory
Results, and Death Certificates for 2012. We also reviewed
cases recorded at the Kumasi South Regional Hospital.
Other sources of data for cancer cases in Kumasi were
Pathology Laboratory Reports, Biostatistics Index Cards,
Out-patient Records and Haematology Laboratory Re-
cords. All cases of cancer were first identified and selected.
Cases specific to Kumasi based on the place of usual resi-
dence were identified and selected for inclusion in our
dataset. Required information including demographic,
tumour and other clinical information were collected. Ab-
stracted data was verified by a clinician before entry into
CanReg 5 database. Further verification of data quality
was conducted by the Registry Manager before confirm-
ation into the database. The International Classification of
Diseases for Oncology (ICD-O3) was used for classifica-
tion and coding of cases of cancers recorded [29].
The incidence of multiple registrations was controlled
by the use of multiple variables including the National
Health Insurance Number, Date of Birth, Hospital ID
number and Age of patient. This was necessitated by
the lack of a single form of identification in Ghana.
Names were not used as recommended [1] because of
the similarity of names as well as variations in the spel-
lings of some names.
Data was exported from Canreg 5 into Microsoft
Excel® and analysed using Epi Info Version® 7.1.2.0. Epi
Info was used to generate means, frequencies and pro-
portions. Microsoft Excel was used to generate charts
and graphs. Canreg 5 was used to generate the crude
and ASRs for the cases recorded.
Approval for the use of data from the Registry for the
purpose of this publication was obtained from the Kumasi
Cancer Registry Advisory Board. Ethical approval was from
the Komfo Anokye Teaching Hospital/Kwame Nkrumah
University of Science and Technology Committee on Hu-
man Research and Publication Ethics.
Results
The majority of cancers recorded for the period were
among females and they accounted for 69.6% of all
cases. The basic demographic information of cancer
cases recorded in Kumasi for 2012 is as shown in
Table 1.
The mean age (SD) at diagnosis for all cases was 51.6
(18.7) years with a median age of 53 years and a range of
1 to 90 years. Among males, the mean age (SD) at diag-
nosis was 48.4 (17.9) years, median age 48 years and a
range of 1 to 90 years. Among females the mean age at





























Figure 1 Basis of diagnosis for cancer cases in Kumasi, 2012.
*includes haematological investigation, ultrasonography and
tumour markers.
Table 2 Tumour types by grade
Grade Frequency Percentage
Well differentiated 17 13.8
Moderately differentiated 61 49.6
Poorly differentiated 35 28.5
Undifferentiated 10 8.1
Total 123 100.00
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a range of 1 to 90 years.
The commonest sites for cancers reported among both
sexes were Breast (24.1%), Cervix Uteri (20.6%), Ovary
(7.9%), Liver (6.4%) and Prostate (4.0%).
The most common cancers among males were cancers
of the Liver (21.1%), Prostate (13.2%), Lung (5.3%) and
Stomach (5.3%). Among females, the commonest can-
cers were cancers of the Breast (33.9%), Cervix (29.4%),
Ovary (11.3%) and Endometrium (4.5%).
The histology of the primary tumour formed the basis
of diagnosis in most (73.71%) of cases. Figure 1 shows
the basis of diagnosis for all cancers in this study.
Among cases histologically diagnosed, grading infor-
mation was not available for 62 of the cases. For the 123
cases with tumour grading information available, mo-
derately differentiated cases were the leading finding ac-
counting for 49.6% of cases. The proportions for the
various grades are as shown in Table 2.
Based on the current population of Kumasi, the es-
timated crude cancer incidence for 2012 was 11.9 per
100,000. Among males, the cancer incidence is 7.3/100,000
and 15.7/100,000 among females. The age-standardised
incidence rates (ASR) for males was 10.9/100,000 and
22.4/100,000 for females. The ASR for the various
tumour sites reported in Kumasi for 2012 is as shownTables 3 and 4. ASR by sex across all age groups is as
shown in Figure 2.
Discussion
Our review of cancer in Kumasi is based on data col-
lected with a reference population in mind in order to
provide the basis for future estimation of the burden of
cancers in Ghana and to assess the progress of cancer
control programmes [1,2,19]. While a national PBCR
may be ideal, the challenges to establishing such regis-
tries may include the lack of a uniform reporting system,
the lack of a single national identification system, the
multiple levels of independent healthcare delivery and
the poor distribution of expertise in cancer diagnosis
and treatment. Our use of multiple variables to reduce
the incidence of multiple registrations is an example of
actions that can be pursued to ensure that quality data
is available for use in cancer prevention and control
programmes.
Kumasi has largely been regarded as being conducive
for the establishment of a PBCR because of the availabil-
ity of laboratories and expertise to manage cancers. It
Table 3 Frequency, age-specific incidence rates, average annual crude incidence rates, and ASR by site in females in Kumasi, 2012
Site All ages 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ Crude rate ASR
Salivary glands 2 - - - - - - - - - - 2.5 - - - - 3.9 0.2 0.2
Stomach 1 - - - - - - - - - - 2.5 - - - - - 0.1 0.1
Colon 1 - - - - - - - - - - - - - - - 3.9 0.1 0.1
Anus 1 - - - - - - - - - - - - 4.5 - - - 0.1 0.2
Gall bladder 1 - - - - - - - - - 2.3 - - - - - - 0.1 0.1
Nose, Sinuses etc. 2 - - - - - - - - 1.8 - - 4.2 - - - - 0.2 0.3
Bone 1 - - 0.8 - - - - - - - - - - - - - 0.1 0.1
Melanoma of skin 1 - - - - - - - - - 2.3 - - - - - - 0.1 0.1
Other skin 1 - - - - - - - - - - - - 4.5 - - - 0.1 0.2
Kaposi Sarcoma 1 - - - - - - 1.5 - - - - - - - - - 0.1 0.1
Connective and soft tissue 3 - 0.7 - 0.9 - - 1.3 - - - - - - - - - 0.3 0.2
Breast 59 - - - - - 2.0 5.1 7.6 10.9 21.1 20.4 29.7 31.2 29.7 22.3 11.6 5.3 7.9
Vulva 2 - - - - - - - - - - - - - - 5.6 3.9 0.2 0.2
Cervix uteri 52 - - - - - - 3.8 1.5 7.3 14.1 15.3 25.5 13.4 44.6 33.5 42.7 4.6 6.8
Corpus uteri 8 - - - - - - - 1.5 - - 5.1 4.2 4.5 7.4 11.2 - 0.7 1.1
Uterus unspecified 1 - - - - - - - - - 2.3 - - - - - - 0.1 0.1
Ovary 20 - - - 0.9 1.8 - 1.3 - - 2.3 10.2 12.7 8.9 14.9 11. 7.8 1.8 2.6
Placenta 3 - - - - - 1.0 1.3 1.5 - - - - - - - - 0.3 0.2
Kidney 2 1.3 - - - - - - - - - - - - - - - 0.2 0.2
Bladder 2 2 - - - - - - - - - - - - - 5.6 3.9 0.2 0.2
Eye 1 - - - 0.9 - - - - - - - - - - - - 0.1 0.1
Brain, nervous system 2 - - - -
Non-Hodgkin lymphoma 8 0.7 1.5 0.8 - 0.9 - - - 1.8 - 2.5 - - - - 3.9 0.7 0.7
Multiple myeloma 1 - - - - - - - - - - - - - - - 3.9 0.1 0.1
Other unspecified 1 - - - - - - - - - - - 4.2 - - - - 0.1 0.2

















Table 4 Frequency, age-specific incidence rates, average annual crude incidence rates, and ASR by site in males in Kumasi, 2012
Site All ages 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ Crude rate ASR
Mouth 1 - - - - - - - - - - - - 5.1 - - - 0.1 0.2
Salivary glands 2 - - - - - - - 1.7 - - 3.0 - - - - - 0.2 0.3
Tonsil 1 - - - - - - - - - - - 4.4 - - - - 0.1 0.2
Oesophagus 1 - - - - - - - - - 2.6 - - - - - - 0.1 0.2
Stomach 4 - - - - - - - - - 2.6 3.0 4.4 5.1 - - - 0.4 0.7
Colon 1 - - - - - - - - - - - - - 8.9 - - 0.1 0.3
Rectum 1 - - - - - - - - - - - - - - 8.1 - 0.1 0.2
Liver 16 0.7 - - - 1.1 2.5 1.5 - 12.2 5.1 - - - 8.9 8.1 5.7 1.6 2.0
Gall bladder 1 - - - - - - - - - 2.6 - - - - - - 0.1 0.2
Larynx 1 - - - - - - - - - - - 4.4 - - - - 0.1 0.2
Trachea, bronchus and lungs 3 - - - - - - - - - - - - 15.4 - - - 0.3 0.6
Bone 2 - - - - 1.1 - - - - 2.6 - - - - - - 0.2 0.2
Other skin 1 - - - - - 1.3 - - - - - - - - - - 0.1 0.1
Mesothelioma 1 - - - - - - - - - - - - - - - 5.7 0.1 0.1
Kaposi Sarcoma 1 - - - - - - - - - - 3.0 - - - - - 0.1 0.1
Connective and soft tissue 4 - - - - - - 3.0 1.7 - - - 4.4 - - - - 0.4 0.5
Breast 1 - - - - - - - - - 2.6 - - - - - - 0.1 0.2
Prostate 10 - - - - - - - - - - - - 25.7 - 16.3 17.2 1.0 1.7
Testis 1 - - - - - - - - - 2.6 - - - - - - 0.1 0.2
Other male genital organs 1 - - - - - - - - 2.0 - - - - - - - 0.1 0.1
Kidney 1 - 0.7 - - - - - - - - - - - - - - 0.1 0.1
Bladder 1 - - - - - - - - - - - - - 8.9 - - 0.1 0.3
Brain, nervous system 1 - - 0.8 - - - - - - - - - - - - - 0.1 0.1
Thyroid 1 - - - - 1.1 - - - - - - - - - - - 0.1 0.1
Adrenal gland 1 - - - - - - 1.5 - - - - - - - - - 0.1 0.1
Hodgkin disease 3 - - 0.8 - - - - - - 5.1 - - - - - - 0.3 0.4
Non-Hodgkin lymphoma 5 - - - - - 2.5 - - - - 3.0 - 5.1 - 8.1 - 0.5 0.7
Lymphoid leukaemia 1 - - - - - - - - 2.0 2.6 3.0 8.9 - - - 5.7 0.1 0.1
Other unspecified 8 - - - - 1.1 - 1.5 - 2.0 - - - - - - - 0.8 1.1






































































Figure 2 Age specific rates (ASR) for all cancers by sex in
Kumasi, 2012.












Urinary bladder 3 1.2
Others 71 28.1
Total 253 100.0
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ing for cases to be easily identified and included in the
registry database. Despite the challenges to cancer regis-
tration in developing countries [1,28], our review of the
first dataset from a PBCR in Ghana indicates that some
of these challenges can be overcome and good quality
population-based data obtained to inform planning and
cancer control activities.
Cancer in Ghana has evolved over the last few de-
cades. While this may not necessarily be indicative of
changes in disease pattern, one of the commonest can-
cers recorded in the late 1950’s was cancer of the Skin
accounting for over a tenth of cancer cases recorded in
Ghana [24]. Although skin cancers were rare in our
dataset, we believe the observed high incidence in the
late 1950s may be due to cases among white Ghanaian
residents as Ghana was a British Colony at the time. Re-
cent mortality reviews among cancer cases have shown
lower rates of skin cancer-related mortality in Ghana [17].
The types of cancers recorded in Kumasi show some
variation from studies on cancers in Ghana as well as
other parts of Africa. There are also some consistencies
observed. The high proportion of female cases is consist-
ent with findings in the Gambia [5], Nigeria [30], Morocco
[31] and from mortality records in Ghana [17]. Breast and
cervical cancers were the leading cancers among females
and this is also consistent with findings in other parts of
Sub-Saharan Africa [5,7,30] although much lower rates
were recorded in Kumasi compared with Ibadan and
Abuja in Nigeria [30]. Liver cancer was the leading cancer
among males in our review and is consistent with findings
in the Gambia [5]. Prostate cancer, although the second
leading cause of cancers in Kumasi among males, ac-
counted for a lower proportion compared with 28% in
Abuja and 23% in Ibadan [30]. Ovarian cancer as a pro-
portion of female cancers was much higher in Kumasi
(11.3%) compared with Nigeria where a proportion of 3%was recorded [30]. Lung cancers accounted for 1.6% for
all cancers in our review and is consistent with findings in
Nigeria (30) as Ghana and Nigeria share similar popula-
tion characteristics. This may be due to the low prevalence
of smoking [11,12] although the proportions are much
lower compared with those recorded in other African
countries as the Gambia (4%), Morocco (19%), [5,31].
Limitations
Our review is limited in terms of coverage by virtue of
the fact that not all possible data sources in the Kumasi
metropolitan area were included in the data collection.
However, we estimate that the majority of cases of can-
cers in Kumasi are seen in KATH as it is the only hos-
pital in the region with the requisite human resource
and logistics to manage cancer cases. We are also likely
to have missed cases among residents who may have
sought treatment elsewhere outside the Kumasi city.
This though may be difficult to ascertain as there cur-
rently exists no national database on cases of diseases
seen in health facilities. It is unlikely that this will be
solved in the near future as challenges exist at the na-
tional level on the quality of data. These may have
accounted for the low incidence recorded. Our ranking
of cancer cases (Table 5) show some consistency with
those recorded by GLOBOCAN. However our estimates
are low and may be due to some of the factors high-
lighted. Despite this, minimal variations are seen in the
leading sites of tumours occurring among both sexes
in Ghana. GLOBOCAN estimates the leading cancers
in descending order as Liver, Prostate, Non-Hodgkin
Lymphoma, Colorectum and Lip and Oral Cavity for
males. Among females, the leading cancers were Cervix,
Breast, Liver, Ovary and Non-Hodgkin Lymphoma [32].
In the absence of any form of population-based data on
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population-based data yet, to be produced in Ghana.
We may also have underestimated the incidence of
breast cancer in Kumasi as a private hospital in Kumasi
was not included in our dataset because of administra-
tive challenges. However, being the only tumour seen at
this clinic, the exclusion of data from this site can only
affect the overall incidence of cancer in Kumasi and
breast cancers in particular but not the ranking of cases
of cancers in Kumasi.
Conclusion
Population-based cancer registries are feasible in devel-
oping countries despite the challenges. Further strength-
ening of the cancer surveillance system in Kumasi in
addition to the establishment of more PBCRs in Ghana
is recommended in order to better estimate cancer inci-
dence in Ghana and allow for evidence-based planning
for cancer prevention and control.
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